|63387T||1 Kit (9 x 20 microliters)||
|COL1A1 (E8F4L) XP® Rabbit mAb 72026||20 µl||
||H M||220||Rabbit IgG|
|Tenascin C (E5J3B) Rabbit mAb 33352||20 µl||
||H||200, 240||Rabbit IgG|
|Thrombospondin-1 (D7E5F) Rabbit mAb 37879||20 µl||
||H M R||170||Rabbit IgG|
|Fibronectin/FN1 (E5H6X) Rabbit mAb 26836||20 µl||
|COL4A1 Antibody 50273||20 µl||
|SPARC (D10F10) Rabbit mAb 8725||20 µl||
||H M||42||Rabbit IgG|
|Periostin (E5F2S) Rabbit mAb 20302||20 µl||
|Anti-rabbit IgG, HRP-linked Antibody 7074||100 µl||
|COL3A1 (E8D7R) XP® Rabbit mAb 63034||20 µl||
|CYR61 (D4H5D) XP® Rabbit mAb 14479||20 µl||
Monoclonal antibodies are produced by immunizing animals with recombinant proteins specific to the carboxy terminus of human Tenascin C protein and human Fibronectin/FN1 protein; with synthetic peptides corresponding to residues surrounding Phe1197 of human COL1A1 protein, Ser395 of human periostin protein, and Pro171 of human CYR61 protein, the amino terminus of human thrombospondin-1 protein and human SPARC protein, and the carboxy terminus of human COL3A1 protein. Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Asp536 of human COL4A1 protein. Antibodies are purified by peptide affinity chromatography.
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.